Riskpilot← Back to searchSign inGet full accessHEMONTO A/S
A/SActiveCVR 29839395Skt. Clemens Torv 8B, 2.Other activities auxiliary to financial services, except insurance and pension funding · NACE 6619Est. 200637 employeeswww.hemonto.com
Revenue 2025
DKK 25,8M
+35% vs 2024
EBITDA margin
12.9%
-8% vs 2024
Equity ratio
52.9%
Financial strength
Net profit 2025
DKK 2,5M
-14% vs 2024
| Revenue | DKK 25,8M | +35% |
| EBITDA | DKK 3,3M | -8% |
| Net profit | DKK 2,5M | -14% |
| Total assets | DKK 11,4M | -15% |
| Equity | DKK 6M | -37% |
| Employees | 37 | — |
Legal name
HEMONTO A/S
CVR number
29839395
Legal form
Aktieselskab
NACE code
6619 · Other activities auxiliary to financial services, except insurance and pension funding
Founded
30. august 2006
Share capital
DKK 2.500.000
Employees
37 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af et flertal af bestyrelsesmedlemmerne i forening.
Company purpose
Selskabets formål er at yde administrativ assistance i forbindelse med kunders investering i værdipapirer og finansielle instrumenter, samt enhver aktivitet, der efter bestyrelsens skøn står i forbindelse hermed.
Address
Skt. Clemens Torv 8B, 2.
Phone
+4587421200
Email
info@hemonto.com
Website
www.hemonto.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.468 | 8.307 | 12.221 | 13.733 | 14.340 | 16.166 | 19.856 | 20.867 | 22.238 | 26.126 | 17.958 | 19.365 | 19.084 | 25.814 |
| Staff expenses | -3.986 | -5.172 | -7.387 | -8.914 | -10.524 | -11.373 | -14.999 | -18.364 | -17.055 | -21.111 | -17.431 | -14.398 | -15.490 | -22.494 |
| EBITDA | 2.482 | 3.135 | 4.834 | 4.819 | 3.816 | 4.794 | 4.857 | 2.503 | 5.184 | 5.016 | 526 | 2.959 | 3.594 | 3.319 |
| Depreciation & amort. | 244 | 291 | 351 | 292 | 436 | -601 | -719 | -396 | -366 | -455 | -0 | -147 | -147 | -147 |
| EBIT | 2.238 | 2.844 | 4.483 | 4.527 | 3.380 | 4.193 | 4.138 | 2.106 | 4.818 | 4.561 | 526 | 2.812 | 3.447 | 3.172 |
| Net financials | -2 | 3 | 28 | 43 | -2 | -26 | -55 | -46 | -6 | 42 | 128 | 61 | 288 | 101 |
| Profit before tax | 2.236 | 2.847 | 4.511 | 4.570 | 3.378 | 4.167 | 4.083 | 2.060 | 4.812 | 4.603 | 655 | 2.873 | 3.734 | 3.273 |
| Tax | 569 | 718 | 1.115 | 1.063 | 706 | 978 | 905 | 456 | 664 | 463 | 218 | 645 | 778 | 729 |
| Net profit | 1.667 | 2.129 | 3.396 | 3.507 | 2.673 | 3.189 | 3.178 | 1.604 | 4.148 | 4.140 | 436 | 2.228 | 2.957 | 2.544 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.504 | 6.207 | 8.771 | 11.578 | 9.998 | 11.316 | 6.317 | 8.207 | 17.557 | 49.057 | 17.602 | 15.759 | 13.360 | 11.388 |
| Equity | 3.391 | 5.205 | 7.001 | 8.008 | 7.181 | 7.700 | 2.577 | 4.182 | 8.330 | 12.470 | 2.936 | 11.670 | 9.627 | 6.021 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 556 | 1.501 | 1.446 | 690 | 714 | 736 | 758 |
| Short-term debt | 1.113 | 1.001 | 1.703 | 3.369 | 2.604 | 3.473 | 3.593 | 3.413 | 7.006 | 33.850 | 13.976 | 3.375 | 2.997 | 4.608 |
| Total debt | 1.113 | 1.001 | 1.703 | 3.369 | 2.604 | 3.473 | 3.593 | 3.969 | 8.507 | 35.296 | 14.666 | 4.089 | 3.733 | 5.366 |
EBITDA margin
12.9%
This company
15.8%
Market median
-18% vs market
20122025
Equity ratio
52.9%
This company
38.2%
Market median
+38% vs market
20122025
Return on equity
42.3%
This company
18.4%
Market median
+130% vs market
20122025
Net profit margin
9.9%
This company
8.1%
Market median
+22% vs market
20122025
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
20122025
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
HS Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
JP Management | Management | 2008 | — | — |
RL Management | Management | 2025 | — | — |
ML Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
TE Management | Management | 2017 | — | — |
MP Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2006 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2015 | — | — | |
| Chairman | 2006 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hemonto Holding ApS | Company | 100.0% | 100.0% | 2022 |
Hemonto Group Holding ApS | Company | 100.0% | 100.0% | 2015 |
TORBEN ENGEDAL HOLDING ApS | Company | 5.0% | 5.0% | 2012 |
LIND INVEST ApS | Company | 66.7% | 66.7% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TORBEN ENGEDAL HOLDING ApS
HEMONTO A/S Board members of HEMONTO A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenneth Buus Kjøge Andersen | Chief Executive Officer | 0 companies |
| Henning Svane | Chief Executive Officer | 0 companies |
| John Palle Andersen | Management | 0 companies |
| Rasmus Lund Madsen | Management | 0 companies |
| Mai Louise Agerskov Andersen | Chief Executive Officer | 0 companies |
| Torben Engedal | Management | 0 companies |
| Mathies Pedersen | Chief Executive Officer | 0 companies |
| Henrik Lind | Board of Directors | 0 companies |
| Martin Høyer-Hansen | Board of Directors | 0 companies |
| Jan Heyn Stubberup | Chairman | 0 companies |
| Jens Peder Tanderup | Board of Directors | 0 companies |
| Steen Aage Bock | Board of Directors | 0 companies |
| Tonny Haahr | Board of Directors | 0 companies |
| Jan Snogdal | Chairman | 0 companies |
| Morten Amstrup Sandlykke | Chairman | 0 companies |
| Ken Gamskjær | Board of Directors | 0 companies |
| Jacob Bye Bjerregaard | Board of Directors | 0 companies |
| Lasse Dehn-Baltzer | Chairman | 0 companies |
| Kent Villadsen Madsen | Chairman | 0 companies |
| Gert Kristiansen | Board of Directors | 0 companies |
| Peter Frisgaard Lauridsen | Board of Directors | 0 companies |
| Daniel Lauritsen | Board of Directors | 0 companies |